Doering W, Blümel E
Klin Wochenschr. 1978 May 15;56(10):497-502. doi: 10.1007/BF01492862.
Our experience with a commercially available kit (Radioimmunoassay DIGOXIN, Boehringer, Mannheim) using (125J)-labelled digoxin and antibody-coated tubes is reported. This simplified method requires only two pepetting steps per sample and results can be obtained in 70 min. The intra- and interassay coefficient of variation ranged between 7% and 8%. The specific digoxin antibody gave no clinical relevant cross-reactions with spironolactone or prednisone (less than 0.0007%). Of the digoxin metabolites the aglucone digoxigenin showed 31% cross-reaction while the more important cardioactive metabolites digoxigenin-bis- and mono-digitoxide had the same binding affinity to the antibody as digoxin, beta-methyldigoxin and beta-acetyldigoxin. Cross-reaction with digitoxin was 6.8%. More than double-fold dilution of serum protein concentration showed little influence on the digoxin values measured. The results obtained by this new kit compare closely with those obtained by our tritium-labelled kit (r = 0.94, p less than 0.001). Therefore, the upper therapeutic limit of 1.9 ng/ml can be adopted for this method.
本文报道了我们使用市售试剂盒(地高辛放射免疫分析试剂盒,勃林格殷格翰公司,曼海姆)的经验,该试剂盒采用(125J)标记的地高辛和抗体包被管。这种简化方法每个样品仅需两个加样步骤,70分钟即可获得结果。批内和批间变异系数在7%至8%之间。地高辛特异性抗体与螺内酯或泼尼松无临床相关交叉反应(小于0.0007%)。在地高辛代谢产物中,地高辛配基显示出31%的交叉反应,而更重要的具有心脏活性的代谢产物双去氧地高辛配基和单去氧地高辛与地高辛、β-甲基地高辛和β-乙酰地高辛对抗体具有相同的结合亲和力。与洋地黄毒苷的交叉反应为6.8%。血清蛋白浓度超过两倍稀释对所测地高辛值影响很小。该新试剂盒获得的结果与我们的氚标记试剂盒获得的结果密切相关(r = 0.94,p小于0.001)。因此,该方法可采用1.9 ng/ml的治疗上限。